Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The angiotensin converting enzyme inhibitor drugs are now standard therapy for patients with
diabetic nephropathy. The hypothesis of this study is that adding a diuretic agent
(furosemide) will decrease the urine protein, which is a sign of disease, more than an
angiotensin converting enzyme inhibitor alone.